Advances in the early detection of lung cancer

Seminars in Respiratory and Critical Care Medicine

Volumn 17, Issue 4, 1996, Pages 335-341

  Tockman, Melvyn S ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER DIAGNOSIS; CARCINOGENESIS; EARLY DIAGNOSIS; HUMAN; LUNG CANCER; PRIORITY JOURNAL; REVIEW;

EID: 0029952620     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1009905     Document Type: Review

References (69)

1. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin 1993;43:7-26
2. Mountain CF. Assessment of the role of surgery for control of lung cancer. Ann Thorac Surg 1977;24:365-73
3. Epstein DM. The role of radiologic screening in lung cancer. Radiol Clin North Am 1990;28:489-95
4. Saccomanno G, Archer VE, Auerbach O, et al. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974;33:256-70
5. Berlin NI, Buncher CR, Fontana RS, et al. The National Cancer Institute cooperative early lung cancer detection program. Am Rev Respir Dis 1984;130:545-9
6. Frost JK, Ball WC Jr, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in The Johns Hopkins study. Am Rev Respir Dis 1984;130:549-54
7. Flehinger BJ, Melamed MD, Zaman MB, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cvtologic screening in the Memorial Sloan-Kettering study. Am Rev Resp Dis 1984;130:555-60
8. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Resp Dis 1984;130:561-5
9. Boucot KR, Horie U, Sokoloff MJ. Lung cancer detected by survey methods. AmJ Public Health 1959;49:793
10. Nash FA, Morgan JM, Tomkins JG. South London lung cancer study. Br Med J 1968;2:715
11. Brett GZ. Bronchial carcinoma in men detected by selective and unselective miniature radiography, a review of 228 cases. Tubercle 1959;40:192
12. Ebeling K, Nischan P. Screening for lung cancer. Results from a case-control study. Int J Cancer 1987;40:141-4
13. Berndt R, Nischan P, Ebeling K. Screening for lung cancer in the middle aged. Int J Cancer 1990;45:229-30
14. Tockman MS Survival and mortality from lung cancer in a screened population - the Johns Hopkins Study. Chest 1986;89:324S-325S
15. Frost JK, Ball WC Jr, Levin ML, Tockinan MS. Final report: lung cancer control, detection and therapy, phase II. NCI Publ No (PHS) N01-CN-45037. Washington, DC: NCI,1984
16. Tockman MS, Levin ML, Frost JK, et al. Screening and detection of lung cancer. In: Aisner J, ed. Lung Cancer. Churchill Livingstone, New York, 1985;25-40
17. Stitik FP, Tockman, MS, Khoury NF. Chest radiology. In: Miller AB, ed. Screening for Cancer. Academic, San Diego, 1985; 163-99
18. Frost JK, Fontana RS, Melamed MD. et al. Early lung cancer detection: summarv and conclusions. Am Rev Resp Dis 1984;130:565-70
19. Frost JK, Ball WC Jr, Levin ML, et al. Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure. J Occ Med 1986;28:692-703
20. Mulshine JL, Tockman MS, Smart CR. Considerations in the development of lung cancer screening tools. J Natl Cancer Inst 1989;81:900-6
21. Prorok PC, Connor RJ. Screening for the early detection of cancer. Cancer Inv 1986;4(3):225-38
22. Kubik A, Parkin DM, Khlat M, et al. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990;45:26-33
23. Mulshine JL, Tockman MS Early detection of lung cancer: where are we? In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer Prevention. JB Lippincott, Philadelphia, 1991;1-8
24. Sporn MB. Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res 1991;51:6215-8
25. Bishop JM. The molecular genetics of cancer. Science 1987;235:305-11
26. Feig LA. The many roads that lead to Ras. Science 1993;260: 767-8.
27. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-8
28. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-8
29. Stanbridge EJ. Human tumor suppressor genes. Annu Rev Genet 1990;24:615-57
30. Takahashi T, Nau MM, Chiba I, et al. p53: A frequent target for genetic abnormalities in lung cancer. Science 1989;246:491-4
31. Varley JM, Brammar WJ, Lane DP, et al. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Oncogene 1991;6:413-21
32. Hollstein MC, Metalf RA, Welsh JA, et al. Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 1990;87:9958-61
33. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-31
34. Sidransky D, Von Eschenbach A, Tsai YC, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991;252:706-9
35. Marks JR, Davidoff AM, Kerns BJ, et al. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 1991;51:2979-84
36. Sidransky D, Mikkelsen T, Schwechheimer K, et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992;355.846-7
37. Nigro JM, Baker S, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 42:705-8
38. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53
39. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9
40. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer Cell 1993;75:1215-25
41. Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38
42. Modrich P. Mismatch repair, genetic stability and cancer. Science 1994;266:1959-60.
43. Mao L, Lee DJ, Tockman MS, et al. Microsatellite alterations as clonal markers in the detection of human cancer. Proc Natl Acad Sci USA 1994;91:9871-5
44. Hung J, Kishimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995;273:558-63
45. Kishimoto Y, Sugio K, Hung JY, et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 1995;87: 1224-9
46. Lippman SM, Peters EJ, Wargovich MJ, et al. Bronchial micronuclei as a marker of an early stage of carcinogenesis in the human tracheobronchial epithelium. Int J Cancer 1990;45:811-5
47. Lam S, MacAulay C, Hung J, et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg 1993;105: 1035-40
48. Tockman MS, Erozan YS, Gupta PK. et al. and the LCEDWG Investigators. The early detection of second primary lung cancers by sputum immunostaining. Chest 1994;106: 385s-390s
49. Tockman MS, Gupta PK, Myers JD, et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: A new approach to early lung cancer detection. J Clin Oncol 1988;6:1685-93
50. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer 1953; 6:963-8
51. Tockman MS, Gupta PK, Pressman NJ, Mulshine JL. Biomarkers of pulmonary disease. In: Schulte P, Perera F, eds. Molecular Epidemiology: Principles and Practices. Academic Press, San Diego 1993, pp 443-68
52. Mao L, Hruban RH, Boyle JO, et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994;54:1634-7
53. Harris CC. p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 1993;262:1980-1
54. Mulshine JL, Cuttitta F, Bibro M, et al. Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. J Immunol 1983;131:497-502
55. Rosen ST, Mulshine JL, Cuttitta F, et al. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies. Cancer Res 1984;44: 2052-61
56. Zhou J, Mulshine JL, Unsworth EJ, et al. Identification of a heterogeneous nuclear ribonucleoprotein (hnRNP) as an early lung cancer detection marker. J Biol Chem 1996;271: 10760-6
57. Tockman MS, Gupta PK, Pressman NJ, Mulshine JL. Cytometric validation of immunocytochemical observations in developing lung cancer. Diagn Cytopathol 1993; 9:615-22
58. Qiao YL. An assessment of a newly developed biomarker of lung cancer. Thesis, Johns Hopkins School of Hygiene. 1996 (Submitted)
59. Bishop JM. Molecular themes in oncogenesis. Cell 1991; 64(2):1235-48
60. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319(9):525-32
61. Chiba I, Takahashi T, Nau MM. et al. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 1990;5:1603-10
62. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78
63. Rodenhuis S, Slebos RJ, Boot AJ, et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 1988;48: 5738-41
64. Merlo A, Gabrielson E, Askin F, Sidransky D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 1994;54:640-2
65. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7
66. Sidransky D. (Editorial) Importance of chromosome 9p loss in human lung cancer. J Natl Cancer Inst 1995;87:1201-2
67. Tockman MS, Qiao YL, Li L, et al. Safe separation of sputum cells from mucoid glycoprotein. Acta Cvtologica 1995; 39:1128-36
68. Weber JL, Wong C. Mutation of human short tandem repeats. Hum Mol Genet 1993;2:1123-8
69. Cairns P, Tokino K, Eby Y, Sidransky D. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 1994;54:1422-4